{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:21:17Z","timestamp":1787624477388,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05488-2","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:02:30Z","timestamp":1779951750000},"page":"17781-17805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation"],"prefix":"10.1007","volume":"399","author":[{"given":"Pranaya L.","family":"Misar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor V.","family":"Otari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal V.","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradyumna P.","family":"Ige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"5488_CR1","doi-asserted-by":"crossref","unstructured":"Aebi H (1974) Catalase. In Methods of enzymatic analysis. pp 673\u2013684. Academic press","DOI":"10.1016\/B978-0-12-091302-2.50032-3"},{"issue":"2","key":"5488_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4132\/jptm.2021.12.27","volume":"56","author":"B Alzahrani","year":"2022","unstructured":"Alzahrani B, Gaballa MM, Tantawy AA, Moussa MA, Shoulah SA, Elshafae SM (2022) Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury. Journal of Pathology and Translational Medicine 56(2):81\u201391","journal-title":"Journal of Pathology and Translational Medicine"},{"issue":"80","key":"5488_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.compbiolchem.2019.03.002","volume":"1","author":"AN Ambhore","year":"2019","unstructured":"Ambhore AN, Kamble SS, Kadam SN, Kamble RD, Hebade MJ, Hese SV, Gaikwad MV, Meshram RJ, Gacche RN, Dawane BS (2019) Design, synthesis and in silico study of pyridine based 1, 3, 4-oxadiazole embedded hydrazine carbothioamide derivatives as potent anti-tubercular agent. Comput Biol Chem 1(80):54\u201365","journal-title":"Comput Biol Chem"},{"issue":"18","key":"5488_CR4","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/eurheartj\/ehn287","volume":"29","author":"DJ Angiolillo","year":"2008","unstructured":"Angiolillo DJ, Capranzano P, Goto S, Aslam M, Desai B, Charlton RK, Suzuki Y, Box LC, Shoemaker SB, Zenni MM, Guzman LA (2008) A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. Eur Heart J 29(18):2202\u20132211","journal-title":"Eur Heart J"},{"key":"5488_CR5","unstructured":"Bharath HB, Vithalkar MP, Baby K, M FS, B S, Nayak Y (2055) Application of network pharmacology in elucidating molecular mechanisms of traditional drugs for pulmonary fibrosis. Revista Brasileira de Farmacognosia 5:1\u201324"},{"key":"5488_CR6","doi-asserted-by":"crossref","unstructured":"Brazee P, Allen N, Knipe R, Redente EF, Le Saux CJ (2025) Peeling back the layers of the bleomycin model of lung fibrosis: lessons learned, factors to consider, and future directions. InSeminars in Respiratory and Critical Care Medicine. Thieme Medical Publishers, Inc","DOI":"10.1055\/a-2649-9402"},{"key":"5488_CR7","doi-asserted-by":"crossref","unstructured":"C\u00e2ndido LD, de Matos NA, Castro TD, de Paula LC, Dos Santos AM, Costa GD, Talvani A, Canguss\u00fa SD, Zin WA, Bezerra FS (2021) Different tidal volumes may jeopardize pulmonary redox and inflammatory status in healthy rats undergoing mechanical ventilation. Oxid Med Cell Longev 2021(1):5196896","DOI":"10.1155\/2021\/5196896"},{"issue":"5","key":"5488_CR8","first-page":"7433","volume":"15","author":"Z Chen","year":"2018","unstructured":"Chen Z, Zhao L, Zhao F, Yang G, Wang JJ (2018) Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF\/HIF-1\u03b1\/ICAM-1 signaling pathway. Oncol Lett 15(5):7433\u20137437","journal-title":"Oncol Lett"},{"key":"5488_CR9","doi-asserted-by":"crossref","unstructured":"Chianese M, Screm G, Salton F, Confalonieri P, Trotta L, Barbieri M, Ruggero L, Mari M, Reccardini N, Geri P, Hughes M (2024) Pirfenidone and nintedanib in pulmonary fibrosis: lights and shadows. Pharmaceuticals 17(6):709","DOI":"10.3390\/ph17060709"},{"issue":"W1","key":"5488_CR10","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357\u2013W364","journal-title":"Nucleic Acids Res"},{"key":"5488_CR11","doi-asserted-by":"crossref","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx.\u00a0Chem Biol Methods Protoc 2015:243\u201350","DOI":"10.1007\/978-1-4939-2269-7_19"},{"issue":"37","key":"5488_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.102067","volume":"1","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S (2024) Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis. Gene Reports 1(37):102067","journal-title":"Gene Reports"},{"issue":"43","key":"5488_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.humgen.2025.201375","volume":"1","author":"S Dasgupta","year":"2025","unstructured":"Dasgupta S (2025) Unravelling genetic commonalities between idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a bioinformatics exploration. Human Gene 1(43):201375","journal-title":"Human Gene"},{"issue":"1","key":"5488_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0006-291X(87)91297-6","volume":"145","author":"TP Devasagayam","year":"1987","unstructured":"Devasagayam TP, Tarachand U (1987) Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 145(1):134\u2013138","journal-title":"Biochem Biophys Res Commun"},{"key":"5488_CR15","doi-asserted-by":"crossref","unstructured":"Feng A, Caro YM, Gardner C, Grischo G, Liang Y, Wickremasinghe PD, Polmann M, Kala M, Marlowe T, Black SM, Knox KS (2023) PTK2-associated gene signature could predict the prognosis of PF. Respir Res 24(1):304","DOI":"10.1186\/s12931-023-02582-4"},{"issue":"1","key":"5488_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1164\/ajrccm.151.1.7812559","volume":"151","author":"M Fujimura","year":"1995","unstructured":"Fujimura M, Kamio Y, Saito M, Hashimoto T, Matsuda T (1995) Bronchodilator and bronchoprotective effects of cilostazol in humans in vivo. Am J Respir Crit Care Med 151(1):222\u2013225","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5488_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-022-01946-6","volume":"23","author":"C Gan","year":"2022","unstructured":"Gan C, Zhang Q, Liu H, Wang G, Wang L, Li Y, Tan Z, Yin W, Yao Y, Xie Y, Ouyang L (2022) Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study. Respir Res 23(1):32","journal-title":"Respir Res"},{"issue":"8","key":"5488_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36(8):2628\u20132629","journal-title":"Bioinformatics"},{"issue":"3","key":"5488_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jep.2004.09.046","volume":"96","author":"LK Gong","year":"2005","unstructured":"Gong LK, Li XH, Wang H, Zhang L, Chen FP, Cai Y, Qi XM, Liu LL, Liu YZ, Wu XF, Huang CG (2005) Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. J Ethnopharmacol 96(3):537\u2013544","journal-title":"J Ethnopharmacol"},{"key":"5488_CR20","doi-asserted-by":"crossref","unstructured":"Gui YS, Wang L, Tian X, Li X, Ma A, Zhou W, Zeng NI, Zhang JI, Cai B, Zhang H, Chen JY (2015) mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis. PloS One 10(9):e0138625","DOI":"10.1371\/journal.pone.0138625"},{"issue":"1","key":"5488_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/1673-5374.175067","volume":"11","author":"H Guo","year":"2016","unstructured":"Guo H, Zhou H, Lu J, Qu Y, Yu D, Tong Y (2016) Vascular endothelial growth factor: an attractive target in the treatment of hypoxic\/ischemic brain injury. Neural Regen Res 11(1):174\u2013179","journal-title":"Neural Regen Res"},{"issue":"16","key":"5488_CR22","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.3390\/ijms23169065","volume":"23","author":"Y Hada","year":"2022","unstructured":"Hada Y, Uchida HA, Umebayashi R, Yoshida M, Wada J (2022) Cilostazol attenuates AngII-induced cardiac fibrosis in apoE deficient mice.\u00a0Int J Mol Sci 23(16):9065","journal-title":"Int J Mol Sci"},{"issue":"03","key":"5488_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3855\/jidc.18877","volume":"18","author":"AB Hamady","year":"2024","unstructured":"Hamady AB, Abd El-Fadeal NM, Imbaby S, Nassar HM, Sakr MG, Marei YE (2024) Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates. The Journal of Infection in Developing Countries 18(03):399\u2013406","journal-title":"The Journal of Infection in Developing Countries"},{"issue":"3","key":"5488_CR24","first-page":"2381","volume":"17","author":"K Han","year":"2019","unstructured":"Han K, Zhang Y, Yang Z (2019) Cilostazol protects rats against alcohol-induced hepatic fibrosis via suppression of TGF-\u03b21\/CTGF activation and the cAMP\/Epac1 pathway. Exp Ther Med 17(3):2381\u20132388","journal-title":"Exp Ther Med"},{"key":"5488_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.713572","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Jiang M, He R, Lv X, Liao X, He Y, Zhang F, Long L, Jiang G, Peng Z, Tao L, Hu G, Meng J (2021) Mefunidone ameliorates bleomycin-induced pulmonary fibrosis in mice. Front Pharmacol 12:713572. https:\/\/doi.org\/10.3389\/fphar.2021.713572","journal-title":"Front Pharmacol"},{"issue":"1","key":"5488_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41420-024-02078-0","volume":"10","author":"Y Hu","year":"2024","unstructured":"Hu Y, Huang Y, Zong L, Lin J, Liu X, Ning S (2024) Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges.\u00a0Cell Death Discov 10(1):301","journal-title":"Cell Death Discov"},{"issue":"1","key":"5488_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41392-024-02011-y","volume":"9","author":"G Huang","year":"2024","unstructured":"Huang G, Yang X, Yu Q, Luo Q, Ju C, Zhang B, Chen Y, Liang Z, Xia S, Wang X, Xiang D (2024) Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K\/AKT\/mTOR pathway.\u00a0Signal Transduct Target Ther 9(1):306","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"5488_CR28","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-2507","volume":"10","author":"P Huang","year":"2022","unstructured":"Huang P, Zhou Y, Li XH, Zhang YN, Cheng HP, Fu JF, Liu W, Yue S, Luo ZQ (2022) N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence. Ann Transl Med 10(11):642","journal-title":"Ann Transl Med"},{"issue":"6","key":"5488_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"R Huey","year":"2007","unstructured":"Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semiempirical free energy force field with charge-based desolvation. J Comput Chem 28(6):1145\u20131152","journal-title":"J Comput Chem"},{"issue":"330","key":"5488_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122008","volume":"1","author":"S Imbaby","year":"2023","unstructured":"Imbaby S, Hattori Y (2023) Stattic ameliorates the cecal ligation and puncture-induced cardiac injury in septic mice via IL-6-gp130-STAT3 signaling pathway. Life Sci 1(330):122008","journal-title":"Life Sci"},{"issue":"1","key":"5488_CR31","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-020-72136-x","volume":"10","author":"S Imbaby","year":"2020","unstructured":"Imbaby S, Matsuda N, Tomita K, Hattori K, Palikhe S, Yokoo H, Hattori Y (2020) Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis. Sci Rep 10(1):15316","journal-title":"Sci Rep"},{"issue":"4","key":"5488_CR32","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.3390\/ijms24043149","volume":"24","author":"Y Ishida","year":"2023","unstructured":"Ishida Y, Kuninaka Y, Mukaida N, Kondo T (2023) Immune mechanisms of pulmonary fibrosis with bleomycin.\u00a0Int J Mol Sci 24(4):3149","journal-title":"Int J Mol Sci"},{"key":"5488_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01710-4","volume":"21","author":"T Ito","year":"2021","unstructured":"Ito T, Zhang E, Omori A et al (2021) Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats. BMC Pulm Med 21:377. https:\/\/doi.org\/10.1186\/s12890-021-01710-4","journal-title":"BMC Pulm Med"},{"issue":"1","key":"5488_CR34","first-page":"45","volume":"7","author":"SN Jangle","year":"2011","unstructured":"Jangle SN (2011) Molecular docking and binding energy studies on neuraminidase of H1N1 reveal possible answers to its resistance to oseltamivir. Bioinformation 7(1):45\u201349","journal-title":"Bioinformation"},{"key":"5488_CR35","doi-asserted-by":"crossref","unstructured":"Jeffers A, Qin W, Owens S, Koenig KB, Komatsu S, Giles FJ, Schmitt DM, Idell S, Tucker TA (2019) Glycogen synthase kinase-3\u03b2 inhibition with 9-ING-41 attenuates the progression of pulmonary fibrosis. Sci Rep 9(1):18925","DOI":"10.1038\/s41598-019-55176-w"},{"issue":"12","key":"5488_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/1440-1681.13004","volume":"45","author":"SL Kabil","year":"2018","unstructured":"Kabil SL (2018) Beneficial effects of cilostazol on liver injury induced by common bile duct ligation in rats: role of SIRT 1 signaling pathway. Clin Exp Pharmacol Physiol 45(12):1341\u20131350","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5488_CR37","doi-asserted-by":"crossref","unstructured":"Katsiki N, Tentolouris N, Marakomichelakis G, Richter D, Giannoukas A, Koufaki P, Papanas N (2022) Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease. BMC Res Notes 15(1):373","DOI":"10.1186\/s13104-022-06264-0"},{"issue":"2","key":"5488_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00213-021-06041-0","volume":"239","author":"A Khadivi","year":"2022","unstructured":"Khadivi A, Shobeiri P, Momtazmaneh S, Samsami FS, Shalbafan M, Shirazi E, Akhondzadeh S (2022) Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial. Psychopharmacology 239(2):551\u2013559","journal-title":"Psychopharmacology"},{"key":"5488_CR39","first-page":"1","volume":"1","author":"RY Kherallah","year":"2022","unstructured":"Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y (2022) Cilostazol: a review of basic mechanisms and clinical uses. Cardiovasc Drugs Ther 1:1\u20136","journal-title":"Cardiovasc Drugs Ther"},{"issue":"177","key":"5488_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117015","volume":"1","author":"SA Khodir","year":"2024","unstructured":"Khodir SA, Imbaby S, Amer MS, Atwa MM, Ashour FA, Elbaz AA (2024) Effect of mesenchymal stem cells and melatonin on experimentally induced peripheral nerve injury in rats. Biomed Pharmacother 1(177):117015","journal-title":"Biomed Pharmacother"},{"issue":"[D1]","key":"5488_CR41","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2020","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al (2020) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49(D1):D1388\u2013D1395. https:\/\/doi.org\/10.1093\/nar\/gkaa971","journal-title":"Nucleic Acids Res"},{"key":"5488_CR42","doi-asserted-by":"crossref","unstructured":"Li J, Wang Y, Wang R, Wu MY, Shan J, Zhang YC, Xu HM (2022) Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification. Heliyon 8(8):e10201","DOI":"10.1016\/j.heliyon.2022.e10201"},{"issue":"94","key":"5488_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.biopha.2017.07.143","volume":"1","author":"J Li","year":"2017","unstructured":"Li J, Xiang X, Gong X, Shi Y, Yang J, Xu Z (2017) Cilostazol protects mice against myocardium ischemic\/reperfusion injury by activating a PPAR\u03b3\/JAK2\/STAT3 pathway. Biomed Pharmacother 1(94):995\u20131001","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"5488_CR44","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-4224","volume":"9","author":"N Li","year":"2021","unstructured":"Li N, Qiu L, Zeng C, Fang Z, Chen S, Song X, Song H, Zhang G (2021) Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis. Ann Transl Med 9(18):1459","journal-title":"Ann Transl Med"},{"issue":"81","key":"5488_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153428","volume":"1","author":"X Li","year":"2021","unstructured":"Li X, Liu X, Deng R, Gao S, Jiang Q, Liu R, Li H, Miao Y, Zhai Y, Zhang S, Wang Z (2021) Betulinic acid attenuated bleomycin-induced pulmonary fibrosis by effectively intervening Wnt\/\u03b2-catenin signaling. Phytomedicine 1(81):153428","journal-title":"Phytomedicine"},{"key":"5488_CR46","doi-asserted-by":"crossref","unstructured":"Liu H, Heenan KM, Coyle L, Chaudhuri N (2024) Progressive pulmonary fibrosis: a need for real world data to solve real world clinical problems. BMJ Med 3(1):e000911","DOI":"10.1136\/bmjmed-2024-000911"},{"issue":"5","key":"5488_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9190","volume":"20","author":"YL Liu","year":"2020","unstructured":"Liu YL, Chen BY, Nie J, Zhao GH, Zhuo JY, Yuan J, Li YC, Wang LL, Chen ZW (2020) Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b2\/Smad\/ERK signaling pathway. Exp Ther Med 20(5):62","journal-title":"Exp Ther Med"},{"issue":"3","key":"5488_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/medsci6030058","volume":"6","author":"C L\u00f3pez-Ram\u00edrez","year":"2018","unstructured":"L\u00f3pez-Ram\u00edrez C, Suarez Valdivia L, Rodr\u00edguez Portal JA (2018) Causes of pulmonary fibrosis in the elderly. Med Sci 6(3):58","journal-title":"Med Sci"},{"issue":"4","key":"5488_CR49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1165\/rcmb.2009-0002OC","volume":"42","author":"Y Lu","year":"2010","unstructured":"Lu Y, Azad N, Wang L, Iyer AK, Castranova V, Jiang BH, Rojanasakul Y (2010) Phosphatidylinositol-3-kinase\/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol 42(4):432\u2013441","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"5488_CR50","doi-asserted-by":"publisher","first-page":"L175","DOI":"10.1152\/ajplung.00063.2015","volume":"310","author":"SK Madala","year":"2016","unstructured":"Madala SK, Thomas G, Edukulla R, Davidson C, Schmidt S, Schehr A, Hardie WD (2016) p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-\u03b1 expression in the lung. American Journal of Physiology-Lung Cellular and Molecular Physiology 310(2):L175\u2013L186","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"1","key":"5488_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13223-022-00734-7","volume":"18","author":"S Mehdizadeh","year":"2022","unstructured":"Mehdizadeh S, Taherian M, Bayati P, Mousavizadeh K, Pashangzadeh S, Anisian A, Mojtabavi N (2022) Plumbagin attenuates bleomycin-induced lung fibrosis in mice. Allergy Asthma Clin Immunol 18(1):93","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"5488_CR52","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s13346-020-00874-6","volume":"11","author":"PP Mehta","year":"2021","unstructured":"Mehta PP, Dhapte-Pawar VS (2021) Repurposing drug molecules for new pulmonary therapeutic interventions. Drug Deliv Transl Res 11(5):1829\u20131848","journal-title":"Drug Deliv Transl Res"},{"key":"5488_CR53","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s11030-020-10129-8","volume":"25","author":"RJ Meshram","year":"2021","unstructured":"Meshram RJ, Bagul KT, Aouti SU, Shirsath AM, Duggal H, Gacche RN (2021) Modeling and simulation study to identify threonine synthase as possible drug target in Leishmania major. Mol Divers 25:1679\u20131700","journal-title":"Mol Divers"},{"issue":"4","key":"5488_CR54","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/07391102.2019.1597770","volume":"38","author":"RJ Meshram","year":"2020","unstructured":"Meshram RJ, Bagul KT, Pawnikar SP, Barage SH, Kolte BS, Gacche RN (2020) Known compounds and new lessons: structural and electronic basis of flavonoid-based bioactivities. J Biomol Struct Dyn 38(4):1168\u20131184","journal-title":"J Biomol Struct Dyn"},{"key":"5488_CR55","doi-asserted-by":"crossref","unstructured":"Meshram RJ, Baladhye VB, Gacche RN, Karale BK, Gaikar RB (2017) Pharmacophore mapping approach for drug target identification: a chemical synthesis and in silico study on novel thiadiazole compounds. J Clin Diagn Res: JCDR 11(5):KF01","DOI":"10.7860\/JCDR\/2017\/22761.9925"},{"issue":"4","key":"5488_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.6026\/97320630005150","volume":"5","author":"RJ Meshram","year":"2010","unstructured":"Meshram RJ, Gavhane AJ, Gaikar RB, Bansode TS, Maskar AU, Gupta AK, Sohni SK, Patidar MA, Pandey TR, Jangle SN (2010) Sequence analysis and homology modeling of laccase from Pycnoporus cinnabarinus. Bioinformation 5(4):150","journal-title":"Bioinformation"},{"issue":"32s","key":"5488_CR57","first-page":"2022","volume":"14","author":"P Misar","year":"2025","unstructured":"Misar P, Otari DK (2025) Cilostazol in pulmonary fibrosis: a molecular docking approach to target protein discovery. J Neonatal Surg 14(32s):2022\u20132030","journal-title":"J Neonatal Surg"},{"key":"5488_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s43094-025-00872-w","volume":"11","author":"P Misar","year":"2025","unstructured":"Misar P, Otari K (2025) Molecular dynamics [MD]simulation-guided design and development of a cilostazol-CD-MOF inhaler and its in vitro evaluation in pulmonary fibrosis. Futur J Pharm Sci 11:115. https:\/\/doi.org\/10.1186\/s43094-025-00872-w","journal-title":"Futur J Pharm Sci"},{"key":"5488_CR59","first-page":"1","volume":"4","author":"PL Misar","year":"2025","unstructured":"Misar PL, Otari KV (2025Jan) Investigation of the protective effect of cilostazol on acute lung injury-mediated inflammation and in silico molecular modelling studies of inflammatory signalling pathway: a repurposing study. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 4:1\u201321","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"10","key":"5488_CR60","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247(10):3170\u20133175","journal-title":"J Biol Chem"},{"issue":"7","key":"5488_CR61","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1039\/C6MD00085A","volume":"7","author":"PP Mogle","year":"2016","unstructured":"Mogle PP, Meshram RJ, Hese SV, Kamble RD, Kamble SS, Gacche RN, Dawane BS (2016) Synthesis and molecular docking studies of a new series of bipyrazol-yl-thiazol-ylidene-hydrazinecarbothioamide derivatives as potential antitubercular agents. MedChemComm 7(7):1405\u20131420","journal-title":"MedChemComm"},{"issue":"1","key":"5488_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver.\u00a0Biochim Biophys Act Gen Subj 582(1):67\u201378","journal-title":"Biochim Biophys Act Gen Subj"},{"issue":"16","key":"5488_CR63","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"J Comput Chem"},{"issue":"92","key":"5488_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107336","volume":"1","author":"NA Motta","year":"2021","unstructured":"Motta NA, Autran LJ, Brazao SC, de Oliveira LR, Scaramello CB, Lima GF, de Brito FC (2021) Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 1(92):107336","journal-title":"Int Immunopharmacol"},{"key":"5488_CR65","doi-asserted-by":"crossref","unstructured":"Murray LA, Habiel DM, Hohmann M, Camelo A, Shang H, Zhou Y, Coelho AL, Peng X, Gulati M, Crestani B, Sleeman MA (2017) Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis. JCI insight 2(16):e92192","DOI":"10.1172\/jci.insight.92192"},{"issue":"1-2","key":"5488_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejps.2012.02.015","volume":"46","author":"MA Nader","year":"2012","unstructured":"Nader MA, Baraka HN (2012) Effect of betulinic acid on neutrophil recruitment and inflammatory mediator expression in lipopolysaccharide-induced lung inflammation in rats. Eur J Pharm Sci 46(1\u20132):106\u2013113","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"5488_CR67","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1124\/mol.118.113217","volume":"94","author":"YJ Oh","year":"2018","unstructured":"Oh YJ, Kim HY, Lee MH, Suh SH, Choi Y, Nam TG, Kwon WY, Lee SY, Yoo YH (2018) Cilostazol improves HFD-induced hepatic steatosis by upregulating hepatic STAMP2 expression through AMPK. Mol Pharmacol 94(6):1401\u20131411","journal-title":"Mol Pharmacol"},{"key":"5488_CR68","unstructured":"Oliveros JC (2007\u20132015) Venny: an interactive tool for comparing lists with Venn\u2019s diagrams [Internet]. Available from: https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html. Accessed\u00a08 Jun 2025"},{"key":"5488_CR69","doi-asserted-by":"crossref","unstructured":"Park SJ, Hahn HJ, Oh SR, Lee HJ (2023) Theophylline attenuates BLM-induced pulmonary fibrosis by inhibiting th17 differentiation.\u00a0Int J Mol Sci 24(2):1019","DOI":"10.3390\/ijms24021019"},{"issue":"1","key":"5488_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discovery 18(1):41\u201358","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"5488_CR71","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/nprot.2006.378","volume":"1","author":"I Rahman","year":"2006","unstructured":"Rahman I, Kode A, Biswas SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1(6):3159\u20133165","journal-title":"Nat Protoc"},{"issue":"5","key":"5488_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095313","volume":"9","author":"D Ragab","year":"2014","unstructured":"Ragab D, Abdallah DM, El-Abhar HS (2014) Cilostazol renoprotective effect: modulation of PPAR-\u03b3, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion. Plos One 9(5):e95313","journal-title":"Plos One"},{"issue":"3","key":"5488_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2009.11.004","volume":"118","author":"AM Ramirez","year":"2010","unstructured":"Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Z\u00fcgel U, Roman J (2010) Vitamin D inhibition of pro-fibrotic effects of transforming growth factor \u03b21 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 118(3):142\u2013150","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"5488_CR74","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1111\/1755-5922.12041","volume":"31","author":"M Sahin","year":"2013","unstructured":"Sahin M, Alizade E, Pala S, Alici G, Ozkan B, Akgun T, Emiroglu Y, Demir S, Yazicioglu MV, Turkmen MM (2013) The effect of cilostazol on right heart function and pulmonary pressure. Cardiovasc Ther 31(6):e88-93","journal-title":"Cardiovasc Ther"},{"issue":"4","key":"5488_CR75","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/hepr.12140","volume":"44","author":"S Saito","year":"2014","unstructured":"Saito S, Hata K, Iwaisako K, Yanagida A, Takeiri M, Tanaka H, Kageyama S, Hirao H, Ikeda K, Asagiri M, Uemoto S (2014) Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride\u2010induced liver fibrosis. Hepatol Res 44(4):460\u2013473","journal-title":"Hepatol Res"},{"key":"5488_CR76","doi-asserted-by":"crossref","unstructured":"Savin IA, Zenkova MA, Sen\u2019kova AV (2022) Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches.\u00a0Int J Mol Sci 23(23):14959","DOI":"10.3390\/ijms232314959"},{"issue":"11","key":"5488_CR77","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u2013504","journal-title":"Genome Res"},{"issue":"7","key":"5488_CR78","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.7150\/thno.94072","volume":"14","author":"M Shao","year":"2024","unstructured":"Shao M, Cheng H, Li X, Qiu Y, Zhang Y, Chang Y, Fu J, Shen M, Xu X, Feng D, Han Y, Yue S, Zhou Y, Luo Z (2024) Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis. Theranostics 14(7):2687\u20132705. https:\/\/doi.org\/10.7150\/thno.94072","journal-title":"Theranostics"},{"key":"5488_CR79","doi-asserted-by":"crossref","unstructured":"Shea BS, Probst CK, Brazee PL, Rotile NJ, Blasi F, Weinreb PH, Black KE, Sosnovik DE, Van Cott EM, Violette SM, Caravan P (2017) Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis. JCI insight 2(9):e86608","DOI":"10.1172\/jci.insight.86608"},{"key":"5488_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists [2021 update]. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac194","journal-title":"Nucleic Acids Res"},{"key":"5488_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-014-0251-7","volume":"14","author":"L Shi","year":"2014","unstructured":"Shi L, Pu J, Xu L, Malaguit J, Zhang J, Chen S (2014) The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population-an updated meta-analysis. BMC Neurol 14:1\u20130","journal-title":"BMC Neurol"},{"issue":"5","key":"5488_CR82","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1042\/bj1230805","volume":"123","author":"TF Slater","year":"1971","unstructured":"Slater TF, Sawyer BC (1971) The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J 123(5):805\u201314","journal-title":"Biochem J"},{"key":"5488_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116130","volume":"13","author":"DV Somanader","year":"2024","unstructured":"Somanader DV, Zhao P, Widdop RE, Samuel CS (2024) The involvement of the Wnt\/\u03b2-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin. Biochem Pharmacol 13:116130","journal-title":"Biochem Pharmacol"},{"key":"5488_CR84","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10565-019-09487-3","volume":"36","author":"D Song","year":"2020","unstructured":"Song D, Tang L, Wang L, Huang J, Zeng T, Fang H, Wang X (2020) Roles of TGF\u03b21 in the expression of phosphoinositide 3-kinase isoform genes and sensitivity and response of lung telocytes to PI3K inhibitors. Cell Biol Toxicol 36:51\u201364","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"5488_CR85","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen R, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Iny Stein T, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan - Golan Y, Kohn A, Rappaport N, Safran M, Lancet D (2016) The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54(1):1.30.1-1.30.33. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Curr Protoc Bioinformatics"},{"key":"5488_CR86","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Annika GL, Fang T, Doncheva NT, Pyysalo S, Bork P\u2021, Jensen LJ\u2021, von Mering C\u2021 (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013646","DOI":"10.1093\/nar\/gkac1000"},{"issue":"3","key":"5488_CR87","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s13311-017-0512-4","volume":"14","author":"SY Tai","year":"2017","unstructured":"Tai SY, Chien CY, Chang YH, Yang YH (2017) Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study. Neurotherapeutics 14(3):784\u2013791","journal-title":"Neurotherapeutics"},{"issue":"11","key":"5488_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, Wu S, Wang Y (2023) SRplot: a free online platform for data visualization and graphing. PLoS One 18(11):e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236","journal-title":"PLoS One"},{"issue":"3","key":"5488_CR89","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0272-5231(05)70158-1","volume":"21","author":"JF Tomashefski Jr","year":"2000","unstructured":"Tomashefski JF Jr (2000) Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21(3):435\u2013466","journal-title":"Clin Chest Med"},{"key":"5488_CR90","doi-asserted-by":"crossref","unstructured":"Tsukioka T, Takemura S, Minamiyama Y, Mizuguchi S, Toda M, Okada S (2017) Attenuation of bleomycin-induced pulmonary fibrosis in rats with S-Allyl cysteine. Molecules 22(4):543","DOI":"10.3390\/molecules22040543"},{"issue":"10","key":"5488_CR91","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1002\/mco2.744","volume":"5","author":"J Wang","year":"2024","unstructured":"Wang J, Li K, Hao D, Li X, Zhu Y, Yu H, Chen H (2024) Pulmonary fibrosis: pathogenesis and therapeutic strategies. MedComm 5(10):e744","journal-title":"MedComm"},{"issue":"3","key":"5488_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14059","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Wang H, Yin G, Zhang YD (2023) Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages. Heliyon 9(3):e14059. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14059","journal-title":"Heliyon"},{"issue":"1","key":"5488_CR93","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s40001-025-02640-1","volume":"30","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen S, Zhou Z, Jiang J, Chen S (2025) Tetrathiomolybdate alleviates bleomycin-induced pulmonary fibrosis by reducing copper concentration and suppressing EMT.\u00a0Eur J Med Res 30(1):394","journal-title":"Eur J Med Res"},{"issue":"3","key":"5488_CR94","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.18632\/aging.202420","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li X, Chen H, Han L, Ji X, Wang Q, Wei L, Miu Y, Wang J, Mao J, Zhang Z (2021) Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1\u03b1 and NF-\u03baB expression. Aging [Albany NY] 13(3):4605","journal-title":"Aging [Albany NY]"},{"issue":"12","key":"5488_CR95","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/15563650.2018.1479527","volume":"56","author":"E Wigenstam","year":"2018","unstructured":"Wigenstam E, Elfsmark L, \u00c5gren L, Akfur C, Bucht A, Jonasson S (2018) Anti-inflammatory and anti-fibrotic treatment in a rodent model of acute lung injury induced by sulfur dioxide. Clin Toxicol 56(12):1185\u20131194","journal-title":"Clin Toxicol"},{"key":"5488_CR96","doi-asserted-by":"crossref","unstructured":"W\u00f3jcik-Pszczo\u0142a K, Ch\u0142o\u0144-Rzepa G, Jankowska A, \u015alusarczyk M, Ferdek PE, Kusiak AA, \u015awierczek A, Pociecha K, Koczurkiewicz-Adamczyk P, Wyska E, P\u0119kala E (2020) A novel, pan-PDE inhibitor exerts anti-fibrotic effects in human lung fibroblasts via inhibition of TGF-\u03b2 signaling and activation of cAMP\/PKA signaling.\u00a0Int J Mol Sci 21(11):4008","DOI":"10.3390\/ijms21114008"},{"issue":"1","key":"5488_CR97","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.1038\/s41598-023-43834-z","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Chen H, Ke S, Mo L, Qiu M, Zhu G, Zhu W, Liu L (2023) Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis. Sci Rep 13(1):16559","journal-title":"Sci Rep"},{"issue":"5","key":"5488_CR98","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3892\/mmr.2016.5005","volume":"13","author":"KU Yan","year":"2016","unstructured":"Yan KU, Gao LN, Cui YL, Zhang YI, Zhou XI (2016) The cyclic AMP signaling pathway: exploring targets for successful drug discovery. Mol Med Rep 13(5):3715\u20133723","journal-title":"Mol Med Rep"},{"issue":"286","key":"5488_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120027","volume":"1","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wang M, Ren Y, Li L, Cao L, Zhang W, Lv K, Sun Z, Nie S (2021) Inhibition of Wnt10b\/\u03b2-catenin signaling alleviates pulmonary fibrogenesis induced by paraquat in vivo and in vitro. Life Sci 1(286):120027","journal-title":"Life Sci"},{"issue":"2","key":"5488_CR100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/157340810791233033","volume":"6","author":"X Yue","year":"2010","unstructured":"Yue X, Shan B, A. Lasky J (2010) TGF-\u03b2: titan of lung fibrogenesis. Curr Enzyme Inhib\u00a06(2):67\u201377","journal-title":"Curr Enzyme Inhib"},{"issue":"1","key":"5488_CR101","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1973163","volume":"2023","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang W, Chen X, Cai Y (2023) Prevention of bleomycin\u2010induced pulmonary inflammation and fibrosis in mice by bilobalide. Evid Based Complement Alternat Med 2023(1):1973163","journal-title":"Evid Based Complement Alternat Med"},{"issue":"6","key":"5488_CR102","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.3892\/mmr.2016.5960","volume":"14","author":"XL Zhang","year":"2016","unstructured":"Zhang XL, Xing RG, Chen L, Liu CR, Miao ZG (2016) PI3K\/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition. Mol Med Rep 14(6):5699\u20135706","journal-title":"Mol Med Rep"},{"issue":"1","key":"5488_CR103","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13287-021-02551-y","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yan Z, Liu Y, Zhang Y, Shi J, Li J, Ji F (2021) Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.\u00a0Stem Cell Res Ther 12(1):470","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5488_CR104","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12951-024-02407-6","volume":"22","author":"M Zheng","year":"2024","unstructured":"Zheng M, Zhu W, Gao F, Zhuo Y, Zheng M, Wu G, Feng C (2024) Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects. J Nanobiotechnol 22(1):136","journal-title":"J Nanobiotechnol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05488-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:01:52Z","timestamp":1787623312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05488-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":104,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5488"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05488-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental methods were carried out with the permission of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) guidelines and regulations with approval number SCI\/IAEC\/2022\u201323\/41.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}